Evidence map›Paper›PMID 30116520›Full record

ArticleClinical and translational allergy2018

Protease resistance of food proteins: a mixed picture for predicting allergenicity but a useful tool for assessing exposure.

Jaap Akkerdaas, Muriel Totis, Brian Barnett, Erin Bell, Tom Davis, Thomas Edrington, Kevin Glenn, Gerson Graser, Rod Herman, Andre Knulst and 11 more

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational allergy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Safety evaluation of blue galdieria extract as a food additive.EFSA journal. European Food Safety Authority · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Statement onEFSA journal. European Food Safety Authority · 2021
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 11 institutions in 4 countries.

Jaap Akkerdaas1Department of Experimental Immunology, Academic Medical Center (AMC), Amsterdam, The Netherlands.
Muriel Totis2Bayer S.A.S, Bayer CropScience, Sophia Antipolis, France.
Brian BarnettFormerly BASF Plant Science, Research Triangle Park, NC 27709 USA.
Erin Bell4Regulatory Division, Product Characterization Center, Monsanto Co., St. Louis, MO USA.
Tom Davis5DuPont Pioneer, DuPont Johnston Research and Development Center, Johnston, IA 50131 USA.
Thomas Edrington4Regulatory Division, Product Characterization Center, Monsanto Co., St. Louis, MO USA.
Kevin Glenn4Regulatory Division, Product Characterization Center, Monsanto Co., St. Louis, MO USA.
Gerson Graser6Syngenta Crop Protection, LLC, Research Triangle Park, NC 27709 USA.
Rod Herman7Dow AgroSciences LLC, Indianapolis, IN 46268 USA.
Andre Knulst8Department of Dermatology and Allergology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.
Gregory Ladics9DuPont Haskell Laboratory, Newark, DE 19711 USA.
Scott McClain6Syngenta Crop Protection, LLC, Research Triangle Park, NC 27709 USA.
Lars K Poulsen10Allergy Clinic, Copenhagen University Hospital at Gentofte, Copenhagen, Denmark.
Rakesh Ranjan11Bayer CropScience LP, Morrisville, NC 27560 USA.
Jean-Baptiste Rascle2Bayer S.A.S, Bayer CropScience, Sophia Antipolis, France.
Hector Serrano11Bayer CropScience LP, Morrisville, NC 27560 USA.
Dave Speijer12Department of Medical Biochemistry, Academic Medical Center (AMC), Amsterdam, The Netherlands.
Rong Wang4Regulatory Division, Product Characterization Center, Monsanto Co., St. Louis, MO USA.
Lucilia Pereira MourièsHealth and Environmental Sciences Institute (HESI), Washington, DC 20005 USA.
Annabelle Capt2Bayer S.A.S, Bayer CropScience, Sophia Antipolis, France.
Ronald van Ree1Department of Experimental Immunology, Academic Medical Center (AMC), Amsterdam, The Netherlands.
Monsanto (United States) · USAcademic Medical Center · NLBayer (France) · FRCovestro (United States) · USSyngenta (United States) · USDuPont (United States) · USGentofte Hospital · DKHealth and Environmental Sciences Institute · USPioneer Hi-Bred · USResearch Triangle Park Foundation · USUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSusceptibility to pepsin digestion of candidate transgene products is regarded an important parameter in the weight-of-evidence approach for allergenicity risk assessment of genetically modified crops. It has been argued that protocols used for this assessment should better reflect physiological conditions encountered in representative food consumption scenarios.

aimTo evaluate whether inclusion of more physiological conditions, such as sub-optimal and lower pepsin concentrations, in combination with pancreatin digestion, improved the performance of digestibility protocols used in characterization of protein stability.

methodsFour pairs of established allergens and their related non/weakly-allergenic counterparts (seed albumins, muscle tropomyosins, plant lipid transfer proteins [LTP] and collagens) plus fish parvalbumin, were subjected to nine combinations of pH (1.2-2.5-4.0) and pepsin-to-protein ratio (PPR: 10-1-0.1 U/µg) for pepsin digestion, followed by pancreatin digestion in the presence of bile salts. Digestion was monitored by SDS-PAGE in conjunction with Coomassie staining and immunoblotting using rabbit antisera and human IgE.

resultsAt pH 4.0 and at PPR 0.1 most proteins, both allergen and non-allergen, were highly resistant to pepsin. Under conditions known to favor pepsin proteolysis, the established major allergens Ara h 2, Pru p 3 and Pen a 1 were highly resistant to proteolysis, while the allergen Cyp c 1 was not. However, this resistance to pepsin digestion only made Ara h 2 and to a lesser extent Pen a 1 and Pru p 3 stand out compared to their non-allergenic counterparts. Largely irrespective of preceding pepsin digestion conditions, pancreatin digestion was very effective for all tested proteins, allergens and non-allergens, except for Cyp c 1 and bovine collagen.

conclusionsSub-optimal pH, low pepsin-to protein ratio, and sequential pepsin and pancreatin digestion protocols do not improve the predictive value in distinguish allergens from non-allergens. Digestion conditions facilitating such distinction differ per protein pair.

Identifiers

PMID30116520
PMCPMC6085708
OpenAlexW2883994022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.